Industry trims support for CME

Share this article:

Pharma and device companies reined in commercial support for CME in 2013—the sixth consecutive annual decrease—data released today by the Accreditation Council for Continuing Medical Education (ACCME) show.

The amount of commercial funding reported by ACCME-accredited providers fell by $12.8 million in real dollars last year, or 1.9% vs. the 2012 level, to $649.5 million. It was a smaller decrease than 2012's 10% decline.

When state-accredited providers were accounted for, the support number dropped 2.2% to $660.0 million, vs. $674 million the year before—although that was still much narrower than 2012's 10.3% slide.

MM&M will run a deeper analysis of the data tomorrow.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.